PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cellsLaura Codarri Deak, Pablo Umaña|Nature|2022Cited by 257
Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor ImmunityEva Sum, Pablo Umaña|Clinical Cancer Research|2021Cited by 62
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activationEva Sum, Pablo Umaña|Journal for ImmunoTherapy of Cancer|2022Cited by 24
Differentiating PD-1+ stem-like CD8 T cells towards distinct effectors with enhanced therapeutic potential by an engineered IL-2 cis-targeted to PD-1Pablo Umaña, Volker Teichgräber|Research Square|2021Cited by 5